Matrix metalloproteinases and their clinical applications in orthopaedics

Clinical Orthopaedics and Related Research

Volumn 428, Issue , 2004, Pages 272-285

  Bramono, Diah S ^a   Richmond, John C ^b   Weitzel, Paul P ^c   Kaplan, David L ^a   Altman, Gregory H ^a  

^a Tufts University   (United States)

^b NEW ENGLAND BAPTIST HOSPITAL   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

APOPTOSIS; CARTILAGE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; ENZYME REGULATION; LIGAMENT; ORTHOPEDICS; PRIORITY JOURNAL; REVIEW; TENDON; TISSUE REGENERATION;

EID: 8644263125     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000144166.66737.3a     Document Type: Review

References (105)

1. Ahrens D, Koch AE, Pope RM, et al: Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 39:1576-1587, 1996.
2. Aigner TA, Zien A, Gehrsitz A, Gebhard PM, McKenna LI: Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44:2777-2789, 2001.
3. Archambault J, Elfervig-Wall M, Tsuzaki M, Herzog W, Banes AJ: Rabbit tendons cells produce MMP-3 in response to fluid flow without significant calcium transients. J Biomech 35:303-309, 2002.
4. Bartlett J, Simmer J, Xue J, et al: Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from porcine enamel organ. Gene 183:123-128, 1996.
5. Bau B, Gebhard M, Haag J, et al: Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 46:2648-2657, 2002.
6. Benbow U, Brinckerhoff C: The AP-1 site and MMP gene regulation: What is all the fuss about? Matrix Biol 15:519-526, 1997.
7. Berton AS, Lorimier S, Emonard H, et al: Contribution of the plasmin/matrix metalloproteinase cascade to the retraction of human fibroblast populated collagen lattices. Mol Cell Biol Res Commun 3:173-180, 2000.
8. Blain EJ, Gilbert SJ, Wardale RJ, et al: Up-regulation of matrix metalloproteinase expression and activation following cyclical compressive loading or articular cartilage in vitro. Arch Biochem Biophys 396:49-55, 2001.
9. Bluteau G, Conrozier T, Mathieu P, et al: Matrix metalloproteinase-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochim Biophys Acta 1526:147-158, 2001.
10. Bosman F, Stamenkovic I: Functional structure and composition of the extracellular matrix. J Pathol 200:423-428, 2003.
11. Celiker M, Ramamurthy N, Xu J-W, et al: Inhibition of adjuvant-induced arthritis by systemic tissue inhibitor of metalloproteinase-4 gene delivery. Arthritis Rheum 46:3361-3368, 2002.
12. Chakraborti S, Mandal M, Das S, et al: Regulation of matrix metalloproteinase: An overview. Mol Cell Biochem 253:269-285, 2003.
13. Cole A, Chubinskaya S, Schumaker B, et al: Chondrocyte matrix metalloproteinase-8: Human articular chondrocytes express neutrophil collagenase. J Biol Chem 271:11023-11026, 1996.
14. Creemers L, Jansen I, Docherty A, et al: Gelatinase A (MMP-2) and cysteine proteinases are essential for the degradation of collagen in soft connective tissue. Matrix Biol 17:35-46, 1998.
15. Cunnane G, FitzGerald O, Beeton C, Cawston TE, Bresnihan B: Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis. Arthritis Rheum 44:2263-2274, 2001.
16. Eggert M, Schulz M, Neeck G: Molecular mechanisms of glucocorticoid action in rheumatic autoimmune diseases. J Steroid Biochem Mol Biol 77:185-191, 2001.
17. Ellerbroek SM, Wu YI, Overall CM, Stack MS: Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem 276:24833-24842, 2001.
18. English WR, Velasco G, Stracke JO, Knauper V, Murphy G: Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25). FEBS Lett 491:137-142, 2001.
19. Fehrenbacher A, Steck E, Rickert M, Roth W, Richter W: Rapid regulation of collagen but not metalloproteinase 1, 3, 13, 14 and tissue inhibitor of metalloproteinase 1, 2, 3 expression in response to mechanical loading of cartilage explants in vitro. Arch Biochem Biophys 410:39-47, 2003.
20. Flannery C, Little C, Caterson B, et al: Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes. Matrix Biol 18:225-237, 1999.
21. Foos MJ, Hickox JR, Mansour PG, Slauterbeck JR, Hardy DM: Expression of matrix metalloprotease and tissue inhibitor of metalloprotease genes in human anterior cruciate ligament. J Orthop Res 19:642-649, 2001.
22. Fraser A, Fearon U, Reece R, et al: Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum 44:2024-2028, 2001.
23. Gepstein A, Shapiro S, Arbel G, et al: Expression of matrix metalloproteinases in articular cartilage of temporomandibular and knee joints of mice during growth, maturation, and aging. Arthritis Rheum 46:3240-3250, 2002.
24. Gingras D, Bousquet-Gagnon N, Langlois S, et al: Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MTI-MMP). FEBS Lett 507:231-236, 2001.
25. Green MJ, Gough AK, Devlin J, et al: Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 42:83-88, 2003.
26. Greenwald RA: Thirty-six years in the clinic without an MMP inhibitor: What hath collagenase wrought? Ann N Y Acad Sci 878:413-419, 1999.
27. Grote K, Flach I, Luchtefeld M, et al: Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ Res 92:e80-e86, 2003.
28. Guedez L, Courtemanch L, Stetler-Stevenson M: Tissue inhibitor of metalloproteinase (TIMP)-I induces differentiation and an antiapoptotic phenotype in germinal center B cells. Blood 92:1342-1349, 1998.
29. Hayakawa T: Multiple functions of tissue inhibitors of metalloproteinases (TIMPs): A new aspect involving osteoclastic bone resorption. J Bone Miner Metab 20:1-13, 2002.
30. Hayakawa T, Yamashita K, Tanzawa K, et al: Growth - promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. FEBS Lett 298:29-32, 1992.
31. Hegemann N, Kohn B, Brunnberg L, Schmidt MF: Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders. Osteoarthritis Cartilage 10:714-721, 2002.
32. Hernandez-Barrantes S, Bernardo M, Toth M, et al: Regulation of membrane type-matrix metalloproteinases. Cancer Biol Ther 12:131-138, 2002.
33. Hernandez-Barrantes S, Shimura Y, Soloway P, et al: Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP. Biochem Biophys Res Commun 281:126-130, 2001.
34. Holmbeck K, Bianco P, Caterina J, et al: MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81-92, 1999.
35. Honda K, Ohno S, Tanimoto K, et al: The effects of high magnitude cyclic tensile load on cartilage matrix metabolism in cultured chondrocytes. Eur J Cell Biol 79:601-609, 2000.
36. Huang W, Li WQ, Dehnade F, Zefarullah M: Tissue inhibitor of metalloproteinase-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilage. J Cell Biochem 85:295-303, 2002.
37. Ishigura N, Ito T, Oguchi T, et al: Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum 44:2503-2511, 2001.
38. Itoh T, Tanioka M, Yoshida H, et al: Reduced angiogenesis and tumor progression in gelatinase-A deficient mice. Cancer Res 58:1048-1051, 1998.
39. Jeffrey J: Interstitial Xollagenases. In Parks W, Mecham R (eds). Matrix Metalloproteinases. San Diego, Academic Press 15-42, 1998.
40. Kafienah W, Al-Fayez F, Hollander AP, Barker MD: Inhibition of cartilage degradation: A combined tissue engineering and gene therapy approach. Arthritis Rheum 48:709-718, 2003.
41. Kerkela E, Bohling T, Herva R, et al: Human macrophage metalloelastase (MMP-12) expression is induced in chondrocytes during fetal development and malignant transformations. Bone 29:487-493, 2001.
42. Kerkvliet EH, Docherty AJ, Beersten W, Everts V: Collagen breakdown in soft connective tissue explants is associated with the level of active gelatinase A (MMP-2) but not with collagenase. Matrix Biol 18:373-380, 1999.
43. Klimiuk P, Sierakowski S, Latosiewicz R, et al: Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis. Rheumatol 41:78-87, 2002.
44. Knauper V, Will H, Lopez-Otin C, et al: Cellular mechanisms for human procollagenase-3 (MMP-13) activation. J Biol Chem 271:17124-17131, 1996.
45. Kobayashi T, Hattori S, Shinkai H: Matrix metalloproteinases-2 and -9 are secreted from human fibroblasts. Acta Derm Venereol 83:105-107, 2003.
46. Kolb C, Mauch S, Peter HH, et al: The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of rheumatoid arthritis patient. Immunol Lett 57:83-88, 1997.
47. Konttinen Y, Ainola M, Valleala H, et al: Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: Different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 58:691-697, 1999.
48. Le J, Rattner A, Chepda T, et al: Production of matrix metalloproteinase 2 in fibroblast reaction to mechanical stress in collagen gel. Arch Dermatol Res 294:405-410, 2002.
49. LeGraverand M, Eggerer J, Vignon E, et al: Assessment of specific mRNA levels in cartilage regions in a lapine model of osteoarthritis. J Orthop Res 20:535-544, 2002.
50. Lohmander L, Roos H, Dahlberg L, et al: Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus. J Orthop Res 12:21-28, 1994.
51. Lutolf MP, Lauer-Fields JL, Schmoekel HG, et al: Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics. Proc Natl Acad Sci USA 100:5413-5418, 2003.
52. Majima T, Marchuk LL, Shrive NG, Frank CB, Hart DA: In-vitro cyclic tensile loading of an immobilized and mobilized ligament autograft selectively inhibits mRNA levels for collagenase (MMP-1). J Orthop Sci 5:503-510, 2000.
53. Manicourt D, Fujimoto N, Obata K, et al: Serum levels of collagenase, stromelysin-1, and TIMP-1: Age- and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis. Arthritis Rheum 37:1774-1783, 1994.
54. Marini S, Fasciglione G, Monteleone G, et al: A correlation between knee cartilage degeneration observed by arthroscopy and synovial proteinases activities. Clin Biochem 36:295-304, 2003.
55. Martignetti J, Al Aqeel A, Al Sewairi W, et al: Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 28:261-265, 2001.
56. Matrisian L: Stromelysin-2. In Barrett A, Rawlings N, Woessner J (eds). Handbook of Proteolytic Enzymes. London, Academic Press 1178-1180, 1998.
57. Mengshol JA, Mix KS, Brinckerhoff CE: Matrix metalloproteinases as therapeutic targets in arthritic diseases: Bull's-eye or missing the mark? Arthritis Rheum 46:13-20, 2002.
58. Millward-Sadler S, Wright M, Davies L. et al: Mechanotransduction via integrins and interleukin-4 results in altered aggrecan and matrix metalloproteinase 3 gene expression in normal, but not osteoarthritic, human articular chondrocytes. Arthritis Rheum 43:2091-2099, 2000.
59. Mudera V, Pleass R, Eastwood M, et al: Molecular responses of human dermal fibroblasts to dual cues: Contact guidance and mechanical load. Cell Motil Cytoskeleton 45:1-9, 2000.
60. Nagase H: Stromelysin 1. In Barrett A, Rawlings N, Woessner J (eds). Handbook of Proteolytic Enzymes. London, Academic Press 1172-1178, 1998.
61. Nagase H: Stromelysins 1 and 2. In Parks W, Mecham R (eds). Matrix Metalloproteinases. San Diego, Academic Press 43-84, 1998.
62. Nemeth J, Rafe A, Steiner M, et al: TIMP-2 growth-stimulatory activity: A concentration- and cell-type specific response in the presence of insulin. Exp Cell Res 224:110-115, 1996.
63. Nordstrom D, Lindy O, Lauhio A, et al: Anti-collagenolytic mechanism of action of doxyclycline treatment in rheumatoid arthritis. Rheumatol Int 17:175-180, 1998.
64. Ohta S, Imai K, Yamashita K, et al: Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage. Lab Invest 78:79-87, 1998.
65. Pap T, Shigeyama Y, Kuchen S, et al: Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum 43:1226-1232, 2000.
66. Patwari P, Cook M, DiMicco M, et al: Proteglycan degradation after injurious compression of bovine and human articular cartilage in vitro. Arthritis Rheum 48:1292-1301, 2003.
67. Posthumus M, Limburg P, Westra J, et al: Serum levels of matrix metalloproteinase-3 in relation to the development of radiological damage in patients with early rheumatoid arthritis. Rheumatol 38:1081-1087, 1999.
68. Prajapati R, Chavally-Mis B, Herbage D, Eastwood M, Brown RA: Mechanical loading regulates protease production by fibroblasts in three-dimensional collagen substrates. Wound Repair Regen 8:226-237, 2000.
69. Riley GP, Curry V, DeGroot J, et al: Matrix metalloproteinase activities and their relationship with collagen remodelling in tendon pathology. Matrix Biol 21:185-195, 2002.
70. Roberts S, Hollander A, Caterson B, et al: Matrix turnover in human cartilage repair tissue in autologous chondrocyte implantation. Arthritis Rheum 44:2586-2598, 2001.
71. Rozanov D, Deryugina E, Ratnikov B, et al: Mutation analysis of membrane type-1 matrix metalloproteinase (MTI-MMP). J Biol Chem 276:25705-25714, 2001.
72. Rozanov D, Ghebrehiwet B, Ratnikov B, et al: The cytoplasmic tail peptide sequence of membrane type-1 matrix metalloproteinase (MT1-MMP) directly binds to 1C1qR, a compartment-specific chaperone-like regulatory protein. FEBS Lett 527:51-57, 2002.
73. Salminen H, Saamanen A-M, Vankemmelbeke M, et al: Differential expression patterns of matrix metalloproteinases and their inhibitors during the development of osteoarthritis in a transgenic mouse model. Ann Rheum Dis 61:591-597, 2002.
74. Sadowski T, Steinmeyer J: Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes. Osteoarthritis Cartilage 9:407-415, 2001.
75. Scott DL: Prognostic factors in early rheumatoid arthritis. Rheumatology (Oxford) 39(Suppl 1):24-29, 2000.
76. Seiki M: Membrane-type Matrix Metalloproteinase 1. In Barrett A, Rawlings N, Woessner J (eds). Handbook of Proteolytic Enzymes. London, Academic Press 1192-1195, 1998.
77. Seliktar D, Nerem R, Galis Z: The role of matrix metalloproteinase-2 in the remodeling of cell-seeded vascular constructs subjected to cyclic strain. Ann Biomed Eng 29:923-934, 2001.
78. Senior R, Shapiro S: Macrophage Elastase. In Barrett A, Rawlings N, Woessner J (eds). Handbook of Proteolytic Enzymes. London, Academic Press 1180-1183, 1998.
79. Shapiro S: Matrix metalloproteinase degradation of extracellular matrix: Biological consequences. Curr Opin Cell Biol 10:602-608, 1998.
80. Skotnicki J, Zask A, Nelson F, et al: Design and synthetic considerations of matrix metalloproteinase inhibitors. Ann N Y Acad Sci 878:61-72, 1999.
81. Slauterbeck JR, Hardy DM: Sex hormones and knee ligament injuries in female athletes. Am J Med Sci 322:196-199, 2001.
82. Smith M, Kung HF, Durum S, et al: TIMP-3 induces cell death by stabilizing TNF-a receptors on the surface of human colon carcinoma cells. Cytokine 9:770-780, 1997.
83. Sternlicht MD, Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516, 2001.
84. Stracke JO, Fosang AJ, Last K, et al: Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). FEBS Lett 478:52-56, 2000.
85. Su S, Grover J, Roughley P, et al: Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints. Rheumatol 18:183-191, 1999.
86. Sun H, Yokota H: Messenger-RNA expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and transcription factors in rheumatic synovial cells under mechanical stimuli. Bone 28:303-309, 2001.
87. Sun H, Yokota H: Altered mRNA level of matrix metalloproteinase-13 in MH7A synovial cells under mechanical loading and unloading. Bone 28:399-403, 2001.
88. Sun H, Yokota H: Reduction of cytokine-induced expression and activity of MMP-1 and MMP-13 by mechanical strain in MH7A rheumatoid synovial cells. Matrix Biol 21:263-270, 2002.
89. Takagi M, Santavirta S, Ida H, et al: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in loose artificial hip joints. Clin Orthop 352:34-45, 1998.
90. Takei I, Takagi M, Santavirta S, et al: Messenger ribonucleic acid expression of 16 matrix metalloproteinases in bone-implant interface tissues of loose artificial hip joints. J Biomed Mater Res 52:613-620, 2000.
91. Tanaka S, Li J, Duncan R, et al: Effects of broad frequency vibration on cultured osteoblasts. J Biomech 36:73-80, 2003.
92. Tetlow L, Adlam D, Woolley D: Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage. Arthritis Rheum 44:585-594, 2001.
93. Valente P, Fassina G, Melchiori A, et al: TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer 75:246-253, 1998.
94. Varghese S, Ramsby ML, Jeffrey JJ, Canalis E: Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rat bone cells. Endocrinology 136:2156-2162, 1995.
95. Vincenti M, Brinckerhoff C: Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: Integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 4:157-164, 2002.
96. Vu T, Werb Z, Gelatinase B: Structure, Regulation and Function. In Parks W, Mecham R (eds). Matrix Metalloproteinases. San Diego, Academic Press 115-148, 1998.
97. Westermarck J, Kahari V-M: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781-792, 1999.
98. Wilson C, Matrisian L: Matrilysin. In Parks W, Mecham R (eds). Matrix Metalloproteinases. San Diego, Academic Press 149-184, 1998.
99. Woessner J: Matrilysin. In Barrett A, Rawlings N, Woessner J (eds). Handbook of Proteolytic Enzymes. London, Academic Press 1183-1187, 1998.
100. Woessner Jr JF: Matrix metalloproteinase inhibition: From the Jurassic to the third millennium. Ann N Y Acad Sci 878:388-403, 1999.
101. Woessner J, Nagase H: Matrix Metalloproteinases and TIMPs. London, Oxford University Press 2000.
102. Yamanaka H, Matsuda Y, Tanaka M, et al: Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. Arthritis Rheum 43:852-858, 2000.
103. Yu A, Murphy A, Stetler-Stevenson W: 72-kDa Gelatinase (gelatinase A): Structure, Activation, Regulation and Substrate Specificity. In Parks W, Mecham R (eds). Matrix Metalloproteinases. San Diego, Academic Press 85-113, 1998.
104. Zhang J, Bai S, Zhang X, et al: The expression of novel membrane-type matrix metalloproteinase isoforms is required for normal development of zebrafish embryos. Matrix Biol 22:279-293, 2003.
105. Zhu Y, Liu X, Skold C, et al: Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gels. Respir Res 2:300-305, 2001.